126 related articles for article (PubMed ID: 7107357)
1. The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer.
Spooner D; Bugden RD; Peckham MJ; Wist EA
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):387-9. PubMed ID: 7107357
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
McDermott BJ; Van den Berg HW; Martin WM; Murphy RF
Br J Cancer; 1983 Nov; 48(5):705-10. PubMed ID: 6639859
[TBL] [Abstract][Full Text] [Related]
3. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
[TBL] [Abstract][Full Text] [Related]
5. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
Urtasun RC; Tanasichuk H; Fulton D; Agboola O; Turner AR; Koziol D; Raleigh J
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):365-9. PubMed ID: 7107353
[TBL] [Abstract][Full Text] [Related]
6. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CCNU and misonidazole in the treatment of advanced colorectal cancer.
Anagnost J; Bennett JM; Sutherland RM; Boros L; Siemann DW; Mulcahy RT
Am J Clin Oncol; 1987 Jun; 10(3):213-5. PubMed ID: 3591741
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
Wong KH; Maezawa H; Urano M
Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
[TBL] [Abstract][Full Text] [Related]
10. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
12. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
Spooner D; Peacock JH; Stephens TC
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the chemosensitization of melphalan by misonidazole.
Randhawa VS; Stewart FA; Denekamp J; Stratford MR
Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
[TBL] [Abstract][Full Text] [Related]
15. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.
Clement JJ; Johnson RK
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):631-4. PubMed ID: 7107387
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma.
Busutti L; Breccia A; Stagni G; Gattavecchia E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1739-43. PubMed ID: 6480456
[TBL] [Abstract][Full Text] [Related]
19. The effect of prolonged high dose misonidazole on tumor response to radiation.
McNally NJ; de Ronde J; Hinchliffe M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
